Europe
Technology has had a massive impact on basically every area of life. One very important part of medical research that technology has been having a noticeable impact on is clinical trials.
Following the U.S. Drug Enforcement Agency’s rescheduling of GW Pharmaceuticals’ Epidiolex from a Schedule I to a Schedule V, other cannabis-based drug development companies believe there is momentum for their medications to gain regulatory approval.
German chemical company BASF, the world’s largest chemical producer, has registered 47 percent of patented marine organism gene sequences, according to a study published in Science Advances in June.
Dragonfly Therapeutics struck a licensing agreement worth up to $695 million with Merck. Merck will license exclusive rights to Dragonfly’s TriNKET technology platform for a number of solid-tumor programs, the company announced today.
UgenTec today announced a new end-point PCR analysis software called FastTyper.
Linzagolix overall efficacy and safety maintained or improved at week 24
NetScientific plc today announces its interim results for the six months ended 30 June 2018.
Nexstim Plc today announces its support for the 10th International Symposium on Navigated Brain Stimulation (NBS) which will be held on 12-13 October 2018 in Berlin, Germany.
VAXIMM AG today announced that the Company will participate in several upcoming events in the fourth quarter of 2018.
Interim results for the six months to 30 June 2018
PRESS RELEASES